Toward a detailed characterization of feline immunodeficiency virus-specific T cell immune responses and mediated immune disorders.
Infection of domestic cats with feline immunodeficiency virus (FIV) is associated with the development of an acquired immunodeficiency syndrome (AIDS). The pathogenesis of FIV is not fully understood but it has been reported that the immune system is progressively impaired during disease progression. As a result, anti-FIV specific immune response will usually not clear the virus and the acute stage is followed by a chronic asymptomatic phase. The overall objective of this study was to characterized FIV-induced immune cellular responses and -mediated immune disorder following the first weeks post-infection. Using both cytokine ELISpot and intracellular staining assays, FIV-specific T cells were monitored at 6, 9 and 12 weeks post-infection. We demonstrated that both IFNgamma(+) and, CD4 and CD8 TNFalpha(+) T cells specifically respond to FIV antigens. These responses were found to reach a peak at 9 weeks post-infection. It was further shown that the TNFalpha(+)CD8(+) responding T cells were contained within a CD8beta(low)CD62L(-) T cell subpopulation, expanded in FIV-infected cats. This T cell subpopulation which present features of activated CD8 T cells was further shown to be susceptible to spontaneous apoptosis following a short-term in vitro culture. Moreover, it was observed that cell death by apoptosis of this T cell subset was increased following FIV antigen-recognition. Therefore, FIV might alter immune homeostasis in inducing chronic activation of TNFalpha(+)CD8(+) T cells which eventually will die following antigen contact while deleting CD4(+) T cells. Interestingly, this study confirmed the strong similarity between FIV and HIV pathogenesis.
Paillot
R
R
Discovery Research, Merial S.A.S., 254 rue Marcel Mérieux BP 7009, 69342 Lyon Cedex 07, France.
Richard
S
S
Bloas
F
F
Piras
F
F
Poulet
H
H
Brunet
S
S
Andreoni
C
C
Juillard
V
V
D000818:Animals; D000956:Antigens, Viral / Q000097:blood; D017209:Apoptosis; D002371:Cat Diseases / Q000276:immunology* / Q000821:virology; D002415:Cats; D005260:Female; D016089:Immunodeficiency Virus, Feline / Q000276:immunology*; D007371:Interferon-gamma / Q000097:blood; D016180:Lentivirus Infections / Q000276:immunology / Q000662:veterinary*; D008213:Lymphocyte Activation; D008297:Male; D013047:Specific Pathogen-Free Organisms; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D014766:Viremia
D000956:Antigens, Viral; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma